VF
OLMA icon

Virtu Financial’s Olema Pharmaceuticals OLMA Stock Holding History

Virtu Financial’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$539K Sell
36,161
-6,276
-15% -$140K 0.02% 549
2025
Q4 		$1.06M Buy
+42,437
New +$755K 0.04% 338
2023
Q2 		– Sell
-10,015
Closed -$35K – 1873
2023
Q1 		$35K Sell
10,015
-3,500
-26% -$14.3K ﹤0.01% 1155
2022
Q4 		$33K Buy
+13,515
New +$39.4K ﹤0.01% 1161

Other funds holding OLMA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.11B AUM 171.34% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $3.61B AUM 203.3% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return

Virtu Financial's OLMA Position: Q1 2026 in Review

Virtu Financial reduced its Olema Pharmaceuticals (OLMA) stake by 15% in Q1 2026, selling an estimated $140K and leaving 36,161 shares worth $539K. The position accounts for 0.02% of the portfolio, ranked #549.

Virtu Financial first reported a position in OLMA in Q4 2022 and has held it in 4 quarters since. The position peaked at $1.06M in Q4 2025. 195 funds tracked by Wall St. Rank hold OLMA as of Q1 2026.

  • Virtu Financial held 36,161 shares of Olema Pharmaceuticals worth $539K as of Q1 2026.
  • Virtu Financial sold 6,276 Olema Pharmaceuticals shares in Q1 2026, an estimated $140K.
  • Olema Pharmaceuticals made up 0.02% of Virtu Financial's portfolio in Q1 2026, its #549 holding.
  • Virtu Financial first reported a position in Olema Pharmaceuticals in Q4 2022 and has held it in 4 quarters since.
  • Virtu Financial's Olema Pharmaceuticals position peaked at $1.06M in Q4 2025.
  • 195 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.